Iris Asllani

Brighton and Sussex Medical School

Upon receiving her Bachelor’s degree in Theoretical Nuclear Physics from the University of Tirana in Albania, Dr. Asllani was awarded a Fulbright scholarship to pursue her Master’s and PhD in Bioengineering at the University of Washington in Seattle, Washington. Following her graduate studies, she joined Columbia University’s then newly established MRI center where she spearheaded the Arterial Spin Labeling Perfusion MRI program. She currently holds a dual appointment as a Research MRI Physicist at the Brighton and
Sussex Medical School in the UK and Associate Professor of Biomedical Engineering at the Rochester Institute of Technology in the USA where she directs the Integrated NeuroImaging Lab. The focus of her research is the development and implantation of multi-modal MRI methods for applications in basic neuroscience and clinical research.

dont miss

Multimodal Functional Imaging of the Diseased Brain

The primary goal of clinical MRI is the development of effective biomarkers that can distinguish the diseased brain from its normal counterpart in early stages. To this end, several methods have been developed that can measure various aspects of the brain’s structure and function. This talk will focus on recent efforts to integrate these methods, including non-MRI based ones, to provide a comprehensive and quantitative assessment of the diseased brain.

EVEN MORE SEMINARS

  • Dr. Simeon Nill: Speaking at the European Neurological Convention

    Dr. Simeon Nill
    The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust

    MR image-guided radiotherapy treatment on the MR-Linac

  • Dr Fred Ushakov: Speaking at the European Neurological Convention

    Dr Fred Ushakov
    University College London Hospital & London School of Ultrasound

    Spina bifida: Early diagnosis at 11-13 weeks of pregnancy

  • Gary Royle: Speaking at the European Neurological Convention

    Gary Royle
    University College London

    Novel imaging and sensor systems for radiotherapy

  • Dr Hugh Harvey: Speaking at the European Neurological Convention

    Dr Hugh Harvey
    Kheiron Medical Technologies

    Deep Learning in Breast Cancer Screening

  • Paul Bentley: Speaking at the European Neurological Convention

    Paul Bentley
    Imperial College London

    How can imaging-AI help stroke management?